Message Font: Serif | Sans-Serif
 
No. of Recommendations: 0
Bought a little more today.....

The bull case is pretty clear in that efficacy is good enough, tolerance is good, and safety (at this point) appears acceptable. Trial design and size are also good. Plus, there is a crying need for a product of this type...Yeah, and that NEJM article plus partnership with Eisai...all to the good...

What we don't know is just how conservative the FDA will really be when faced with the possibility of 10,000,000 patients on the drug for extended periods of time. And many of these p will have other conditions which may be aggravated by the drug...

Hmmmmm...times like these call for Dave to make the shorts case, or not, if it isn't a slam dunk...

--s

I think it was ARNA where I read their application to the FDA had 3,200,000 pages??? Is this normal...
Print the post  

Announcements

What was Your Dumbest Investment?
Share it with us -- and learn from others' stories of flubs.
When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Community Home
Speak Your Mind, Start Your Blog, Rate Your Stocks

Community Team Fools - who are those TMF's?
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.
Advertisement